Evidence map›Paper›PMID 39625590›Full record

ReviewArchives of pharmacal research2024

Biological insights and therapeutic potential of Glycyrrhiza uralensis and its bioactive compounds: an updated review.

Sibhghatulla Shaikh, Khurshid Ahmad, Jeong Ho Lim, Syed Sayeed Ahmad, Eun Ju Lee, Inho Choi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of pharmacal research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Integration of Non-Invasive Micro-Test Technology andInternational journal of molecular sciences · 2025
    Article
  6. Integrative Assessment ofInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sibhghatulla Shaikh *Department of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea.
Khurshid Ahmad *Department of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea.
Jeong Ho LimDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea.
Syed Sayeed AhmadDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea.
Eun Ju LeeDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea.
Inho ChoiDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea. inhochoi@ynu.ac.kr.

Funding

National Research Foundation of Korea 2020R1A6A1A03044512
6 · The paper itself

Abstract

The recent resurgence of traditional medicines, driven by a renewed interest in the medicinal use of plant extracts, has garnered significant scientific attention for their therapeutic efficacy in treating a wide range of diseases. Glycyrrhiza species, commonly known as licorice, are widely recognized both as herbal remedies and as natural sweeteners. Among these, Glycyrrhiza uralensis stands out for its exceptional therapeutic potential, particularly in enhancing muscle regeneration, slowing muscle aging, and promoting skeletal muscle myogenesis. This review explores the traditional uses and biological effects of G. uralensis, highlighting the biological significance of its bioactive constituents, such as saponins and flavonoids. The hepatoprotective, antibacterial, antioxidant, anticancer, antidiabetic, antiobesity, anti-inflammatory, skeletal muscle-enhancing and cardiovascular effects of G. uralensis are reviewed, along with its toxicity and safety profile. Additionally, we propose directions for future clinical and scientific investigations, advocating for using G. uralensis as a natural therapeutic agent. The primary aim of this review is to contribute to the incorporation of this ancient medicine into modern clinical practice.

Indexed as

AnticancerAnti-inflammatoryAntioxidantBioactive compoundsGlycyrrhiza uralensisTraditional medicines

Identifiers

PMID39625590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.